• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国正常眼压性青光眼中降低眼压的潜在益处。

Potential benefit of intraocular pressure reduction in normal-tension glaucoma in South Korea.

作者信息

Seong Gong Je, Rho Sae Heun, Kim Chang Sik, Moon Jong Il, Kook Michael Scott, Kim Yong Yeon, Ma Kyoung Tak, Hong Young Jae, Nelson Lindsay A, Kruft Bonnie, Stewart Jeanette A, Stewart William C

机构信息

Yonsei University, Seoul, Korea.

出版信息

J Ocul Pharmacol Ther. 2009 Feb;25(1):91-6. doi: 10.1089/jop.2008.0056.

DOI:10.1089/jop.2008.0056
PMID:19232005
Abstract

PURPOSE

The aim of this study was to evaluate the potential benefit of intraocular pressure (IOP) reduction in normal tension glaucoma (NTG) Asian adult patients in South Korea.

METHODS

This was a retrospective, multicenter analysis of 166 NTG Asian adult patients in South Korea. The patient population consisted of Korean patients with NTG with at least 5 years of records available for evaluation. Patients all had typical glaucomatous optic-disc and/or visual-field changes but had never had a recorded IOP >21 mmHg.

RESULTS

Overall, 48 (29%) patients were progressed and 116 (71%) were stable over the follow-up period. Of patients with IOPs <or=14 mmHg (21/93), 23% progressed and >or=15 mmHg (27/73) 37% progressed (P = 0.041). The mean IOP for the stable group was 14.0 +/- 1.8 mmHg, whereas with the progressed group the average mean IOP was 14.4 +/- 1.6 mmHg (P = 0.20). The mean peak IOP was 17.4 +/- 2.2 mmHg in the stable group and 17.8 +/- 2.0 mmHg in the progressed group (P = 0.26). Multivariate linear regression analysis did not any identify independent risk factors for progression, including age, gender, or mean and peak IOP.

CONCLUSIONS

This study provides initial evidence that Korean patients with normal-tension glaucoma, treated to lower IOPs, may have a decreased incidence of progression over 5 years than those patients with higher IOPs. More research is required to confirm this finding.

摘要

目的

本研究旨在评估降低眼压对韩国正常眼压性青光眼(NTG)成年亚洲患者的潜在益处。

方法

这是一项对韩国166例NTG成年亚洲患者的回顾性多中心分析。患者群体包括有至少5年可用于评估记录的韩国NTG患者。所有患者均有典型的青光眼性视盘和/或视野改变,但眼压从未记录超过21 mmHg。

结果

总体而言,在随访期间,48例(29%)患者病情进展,116例(71%)患者病情稳定。眼压≤14 mmHg的患者(21/93)中,23%病情进展;眼压≥15 mmHg的患者(27/73)中,37%病情进展(P = 0.041)。稳定组的平均眼压为14.0±1.8 mmHg,而进展组的平均眼压为14.4±1.6 mmHg(P = 0.20)。稳定组的平均最高眼压为17.4±2.2 mmHg,进展组为17.8±2.0 mmHg(P = 0.26)。多变量线性回归分析未发现任何病情进展的独立危险因素,包括年龄、性别或平均眼压和最高眼压。

结论

本研究提供了初步证据,表明接受治疗以降低眼压的韩国正常眼压性青光眼患者在5年期间病情进展的发生率可能低于眼压较高的患者。需要更多研究来证实这一发现。

相似文献

1
Potential benefit of intraocular pressure reduction in normal-tension glaucoma in South Korea.韩国正常眼压性青光眼中降低眼压的潜在益处。
J Ocul Pharmacol Ther. 2009 Feb;25(1):91-6. doi: 10.1089/jop.2008.0056.
2
Intraocular pressure reduction in normal-tension glaucoma patients in South Korea.韩国正常眼压性青光眼患者的眼压降低情况
Int Ophthalmol. 2011 Oct;31(5):355-61. doi: 10.1007/s10792-011-9463-7. Epub 2011 Sep 8.
3
Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients.0.005%拉坦前列素或0.2%酒石酸溴莫尼定对正常眼压性青光眼患者眼压及眼灌注压的影响
Ophthalmology. 2002 Dec;109(12):2241-7. doi: 10.1016/s0161-6420(02)01247-2.
4
Influence of intraocular pressure reduction on progression of normal-tension glaucoma with myopic tilted disc and associated risk factors.眼压降低对伴有近视倾斜盘的正常眼压性青光眼进展及相关危险因素的影响。
Jpn J Ophthalmol. 2017 May;61(3):230-236. doi: 10.1007/s10384-017-0508-y. Epub 2017 Mar 9.
5
Correlation between intraocular pressure level and optic disc changes in high-tension glaucoma suspects.高眼压性青光眼可疑患者眼压水平与视盘改变的相关性
Ophthalmology. 2003 May;110(5):915-21. doi: 10.1016/S0161-6420(03)00101-5.
6
Mean target intraocular pressure and progression rates in chronic angle-closure glaucoma.慢性闭角型青光眼的平均目标眼压及进展率
J Ocul Pharmacol Ther. 2009 Feb;25(1):71-5. doi: 10.1089/jop.2008.0061.
7
Long-term benefit of reduced intraocular pressure in primary open-angle glaucoma patients in Ethiopia.埃塞俄比亚原发性开角型青光眼患者眼压降低的长期益处。
Eur J Ophthalmol. 2010 Mar-Apr;20(2):310-5. doi: 10.1177/112067211002000209.
8
Comparison of the Progression of High- and Low-tension Glaucoma as Determined by Two Different Criteria.两种不同标准判定的高眼压性青光眼和低眼压性青光眼进展情况的比较
Korean J Ophthalmol. 2016 Feb;30(1):40-7. doi: 10.3341/kjo.2016.30.1.40. Epub 2016 Jan 21.
9
The effect of latanoprost on intraocular pressure during 12 months of treatment for normal-tension glaucoma.拉坦前列素对正常眼压性青光眼治疗12个月期间眼压的影响。
Korean J Ophthalmol. 2005 Dec;19(4):297-301. doi: 10.3341/kjo.2005.19.4.297.
10
Variations in optic nerve head morphology by intraocular pressure in open-angle glaucoma.开角型青光眼中眼压导致的视神经乳头形态变化
Graefes Arch Clin Exp Ophthalmol. 2017 Nov;255(11):2219-2226. doi: 10.1007/s00417-017-3779-6. Epub 2017 Sep 5.

引用本文的文献

1
Neuroprotection for treatment of glaucoma in adults.用于治疗成人青光眼的神经保护。
Cochrane Database Syst Rev. 2017 Jan 25;1(1):CD006539. doi: 10.1002/14651858.CD006539.pub4.
2
Twenty-four-hour intraocular pressure and ocular perfusion pressure characteristics in newly diagnosed patients with normal tension glaucoma.新诊断的正常眼压性青光眼患者的24小时眼压和眼灌注压特征
Eye (Lond). 2016 Nov;30(11):1481-1489. doi: 10.1038/eye.2016.168. Epub 2016 Jul 29.
3
Neuroprotection for treatment of glaucoma in adults.用于治疗成人青光眼的神经保护作用。
Cochrane Database Syst Rev. 2013 Feb 28;2(2):CD006539. doi: 10.1002/14651858.CD006539.pub3.
4
Intraocular pressure reduction in normal-tension glaucoma patients in South Korea.韩国正常眼压性青光眼患者的眼压降低情况
Int Ophthalmol. 2011 Oct;31(5):355-61. doi: 10.1007/s10792-011-9463-7. Epub 2011 Sep 8.
5
Neuroprotection for treatment of glaucoma in adults.用于治疗成人青光眼的神经保护。
Cochrane Database Syst Rev. 2010 Feb 17(2):CD006539. doi: 10.1002/14651858.CD006539.pub2.